Conatus spikes after hours on Novartis NASH deal

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) gained $2.63 (134%) to $4.59 in early after-hours trading after it announced a co-development deal with Novartis AG (NYSE:NVS; SIX:NOVN) for its nonalcoholic

Read the full 275 word article

How to gain access

Continue reading with a
two-week free trial.